A value-based insurance design program at a large company boosted medication adherence for employees with chronic illnesses

Health Affairs

Volumn 30, Issue 1, 2011, Pages 109-117

  Gibson, Teresa B ^a   Wang, Sara ^f   Kelly, Emily ^b   Brown, Candace ^c   Turner, Christine ^d   Frech Tamas, Feride ^e   Doyle, Joseph ^e   Mauceri, Edward ^f  

^a THOMSON REUTERS   (United States)

^b Thomson Reuters   (United States)

^c Thomson Reuters   (United States)

^d THOMSON REUTERS   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CARDIOVASCULAR AGENT;

ADULT; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COST; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DRUG INDUSTRY; DRUG USE; EMPLOYEE; FEMALE; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; META ANALYSIS; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRESCRIPTION; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; CHRONIC DISEASE; COST SHARING; FEMALE; HEALTH BENEFIT PLANS, EMPLOYEE; HEALTH CARE COSTS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79951590391     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2010.0510     Document Type: Article

References (21)

1. Keeler EB. Effects of cost sharing on use of medical services and health. J Med Pract Manag. 1992;8:317-21.
2. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11:730-40. (Pubitemid 41608213)
3. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298(1):61-9. (Pubitemid 47026771)
4. Roemer MI, Hopkins CE, Carr L, Gartside F. Copayments for ambulatory care: penny-wise and pound-foolish. Med Care. 1975;13(6):457-66.
5. Kozma CM, Reeder CE, Lingle EW. Expanding drug formulary coverage: effects on utilization of related services. Med Care. 1990;28(10):963-77.
6. Chernew ME, Rosen AB, Fendrick AM. Value-based insurance design. Health Aff (Millwood). 2007;26(2):w195-203. DOI: 10.1377/hlthaff.26.2.w195.
7. Fendrick AM, Smith DG, Chernew ME, Shah SN. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. Am J Manag Care. 2001;7(9):861-7. (Pubitemid 32904146)
8. Mahoney JJ. Value-based benefit design: using a predictive modeling approach to improve compliance. J Manag Care Pharm. 2008;14(6 Suppl B):3-8.
9. Chernew ME, Shah MR, Wegh A, Rosenberg SN, Juster IA, Rosen AB, et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood). 2008;27(1):103-12. (Pubitemid 351198595)
10. Kelly EJ, Turner CJ, Frech-Tamas F, Doyle JJ, Mauceri EG. Value-based benefit design and healthcare utilization in asthma, hypertension, and diabetes. Am J Pharm Benefits. 2009;1(4):217-21.
11. Mahoney JJ. Reducing patient drug acquisition costs can lower diabetes health claims. Am J Manag Care. 2005;11(5 Suppl):S170-6.
12. Asthma medications included short-acting beta agonists, long-acting inhaled beta agonists, leukotriene modifiers, inhaled corticosteroids, methylxanthines, and mast cell stabilizers, as well as any combination of these drugs. Cardiovascular medications included angiotensin-converting enzyme (ACE) inhibitors, alpha- and beta-blockers, calcium channel blockers, angiotensin II receptor blockers (ARBs), diuretics, central alpha-2 agonists, and aldosterone receptor blockers. Diabetes medications included insulin and oral hypoglycemics.
13. Briesacher BA, Andrade SE, Fouayzi H, Chan A. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437-43. (Pubitemid 351466455)
14. As a sensitivity analysis, we also calculated the threshold at 80 percent.
15. Diagnosis codes and diagnosis-related groups (DRGs) were based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), codes for asthma (ICD-9-CM 493.x; DRG 96, 97, 98), diabetes (ICD-9-CM 250.x; DRG 294, 295), and diseases of the circulatory system (ICD-9-CM 301.x-459.x), where x is any digit 0-9 that represents a valid diagnosis code. Excluded fromthat range were codes 430.x-438.x and some other codes (for example, 403.x, for hypertensive chronic kidney disease). Also included were many codes in the range 745.x-747.x (for bulbus cordis anomalies, anomalies of cardiac septal closure, other congenital anomalies of the heart, and other congenital anomalies of the circulatory system). Additional codes included those indicating carditis, pericarditis, endocartitis, or myocarditis; peripheral circulatory disorders; injuries to the heart; complications as a result of cardiac devices; and other cardiovascular diagnoses. DRGs included most of those in major diagnostic category 5, diseases and disorders of the circulatory system. The complete list is available upon request.
16. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075-9.
17. Ashcraft ML, Fries BE, Nerenz DR, Falcon SP, Srivastava SV, Lee CZ. A psychiatric patient classification system: an alternative to diagnosis-related groups. Med Care. 1989;27(5):543-57.
18. To access the Appendix, click on the Appendix link in the box to the right of the article online.
19. Chernew ME, Juster IA, Shah M, Wegh A, Rosenberg S, Rosen AB, et al. Evidence that value-based insurance can be effective. Health Aff (Millwood). 2010;29(3):530-6.
20. Fendrick AM, Chernew ME, Levi GW. Value-based insurance design: embracing value over cost alone. Am J Manag Care. 2009;15(10 Suppl):S277-83.
21. Kaiser Family Foundation, Health Research and Educational Trust. Employer health benefits: 2009 annual survey [Internet]. Menlo Park (CA): KFF; 2009 Sep [cited 2010 Apr 8]. Available from: http://ehbs.kff.org/pdf/2009/7936.pdf